Next Article in Journal
Computational Modeling for Neuropsychological Assessment of Bradyphrenia in Parkinson’s Disease
Next Article in Special Issue
Salivary Gland Dysfunction, Protein Glycooxidation and Nitrosative Stress in Children with Chronic Kidney Disease
Previous Article in Journal
Stability and Predictors of Poor 6-min Walking Test Performance over 2 Years in Patients with COPD
 
 
Article
Peer-Review Record

Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases

J. Clin. Med. 2020, 9(4), 1157; https://doi.org/10.3390/jcm9041157
by Saverio Capodiferro 1,†, Giuseppe Ingravallo 2,*,†, Luisa Limongelli 1, Mauro Giuseppe Mastropasqua 2, Angela Tempesta 1, Gianfranco Favia 1 and Eugenio Maiorano 2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
J. Clin. Med. 2020, 9(4), 1157; https://doi.org/10.3390/jcm9041157
Submission received: 1 April 2020 / Revised: 13 April 2020 / Accepted: 14 April 2020 / Published: 18 April 2020
(This article belongs to the Special Issue Diseases of the Salivary Glands)

Round 1

Reviewer 1 Report

The present paper describes a novel variant of mucoepidermoid carcinoma (MEC) of the minor salivary glands, the intracystic variant.

The paper is very interesting. Intracystic low-grade carcinomas are well known in the breast a distinctive entity. In this paper the concept has been applied to intra-oral MEC.

The study is based on 14 cases, with good clinic-pathological details and long follow-up.

The results are very interesting. It is suggested to better specified the diagnostic criteria used to diagnose the pure  intracystic carcinoma. Specifically: was a myoepithelial layer present? If present how it was evaluated? CK14 and p63 stain the basaloid cells usually present in MEC. Were calponin or smooth muscle actin applied? Was a fibrous wall present? It is suggested to propose a clear definition of “pure intracystic MEC”.

Results:”…. also, tumor-free margins were assessed in all cases.”: distance in mm from tumour to the closest margin should be reported.

Results: “Patients had been followed-up for a minimum of 5 years and had remained without evidence of disease up to January 2019”: follow-up length should be reported (range and mean).

Discussion: “In addition, we would also like to emphasize that we were unable to identify MEC with exclusive intra-cystic (in situ) growth in major salivary glands but this may be related to higher chances to detect such tumors at an earlier growth phase when located in intra-oral sites, in view of easier accessibility to inspection and palpation. In other words, we cannot exclude that intra-cystic (in situ) MEC may be present in major salivary glands but, possibly, they remain undetected for longer times and are disclosed when infiltration of adjacent tissues has already occurred.” This is a very important point, but it is not well evident in the Results section.

Discussion: a parallel witu intracystica breast carcinoma should be considered.

Discussion: a fee sentences of conclusions, focusing on the importance to diagnose this new MEC variant should be added.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

This retrospective study about intra-cystic MEC is very interesting and I think it is scientific significant. I have  some proposals:

  1. It will be helpful if authors show what is the frequency of this tumor. They found 14 but from how many MEC.
  2. It will be more clear if they marked somehow the nodule in Figure 1

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop